<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01310192</url>
  </required_header>
  <id_info>
    <org_study_id>RA-2004-040</org_study_id>
    <secondary_id>PC04130</secondary_id>
    <nct_id>NCT01310192</nct_id>
  </id_info>
  <brief_title>Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography</brief_title>
  <official_title>Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Queen's Medical Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United States Department of Defense</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Queen's Medical Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this project is to develop and evaluate fluorine-18 (F-18) fluorocholine (FCH)
      positron emission tomography (PET) as an imaging technique that can be used to delineate
      malignant tumors in the prostate gland. The proposed technique works by measuring the tissue
      metabolism of FCH, a substrate that is preferentially metabolized by cancer cells due to
      malignant over-expression of the choline transporter and choline kinase enzyme. The project
      scope covers a clinical study to recruit men with prostate cancer who have elected treatment
      by radical prostatectomy surgery. These men will undergo pre-operative PET scanning to
      measure F-18 FCH uptake in anatomical sextants of the prostate gland. Imaging results will be
      compared to histopathologic analyses of the prostatectomy specimen to determine the accuracy
      of F-18 FCH PET for detecting cancerous prostate sextants.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2004</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Histopathologic Diagnosis - sextant diagnosis by whole-prostate step section histopathologic analysis</measure>
    <time_frame>Immediate - no longitudinal data collected</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational Imaging Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fluourine-18 Fluoromethylcholine PET/CT Imaging</intervention_name>
    <description>Single-dose Study</description>
    <arm_group_label>1</arm_group_label>
    <other_name>18F-choline PET/CT</other_name>
    <other_name>Fluorocholine PET/CT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinically Organ Confined Prostate Cancer Electing Radical Prostatectomy

        Exclusion Criteria:

          -  Weight &gt; 300 lb
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tripler Army Medical Center</name>
      <address>
        <city>Tripler</city>
        <state>Hawaii</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>DeGrado TR, Kwee SA, Coel MN, Coleman RE. The impact of urinary excretion of (18)F-labeled choline analogs. J Nucl Med. 2007 Jul;48(7):1225.</citation>
    <PMID>17607041</PMID>
  </reference>
  <reference>
    <citation>Kwee SA, Coel MN, Lim J, Ko JP. Prostate cancer localization with 18fluorine fluorocholine positron emission tomography. J Urol. 2005 Jan;173(1):252-5.</citation>
    <PMID>15592091</PMID>
  </reference>
  <results_reference>
    <citation>Kwee SA, Thibault GP, Stack RS, Coel MN, Furusato B, Sesterhenn IA. Use of step-section histopathology to evaluate 18F-fluorocholine PET sextant localization of prostate cancer. Mol Imaging. 2008 Jan-Feb;7(1):12-20.</citation>
    <PMID>18384719</PMID>
  </results_reference>
  <results_reference>
    <citation>Kwee SA, DeGrado TR, Talbot JN, Gutman F, Coel MN. Cancer imaging with fluorine-18-labeled choline derivatives. Semin Nucl Med. 2007 Nov;37(6):420-8. Review.</citation>
    <PMID>17920349</PMID>
  </results_reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2009</study_first_submitted>
  <study_first_submitted_qc>March 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2011</study_first_posted>
  <last_update_submitted>October 1, 2015</last_update_submitted>
  <last_update_submitted_qc>October 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

